Abstract
The successful cloning of a mammal from an adult somatic cell nucleus opens
new avenues for major advances in reproductive medicine, biotechnology and
cellular-based transplantation therapies for degenerative diseases. At the
same time, this breakthrough has generated much heated discussion concerning
the ethics of cloning. Twinning is a form of cloning, and there are instances
in clinical assisted reproduction in which the deliberate formation of twins
by embryo dissection would seem ethically acceptable. Nuclear transfer
technology might facilitate the derivation of human embryonic stem cells,
capable of differentiation into a wide variety of somatic cell lineages.
Directed differentiation of human embryonic stem cells into specific cell
types in vitro could provide a universal source of cells
for transplantation therapy. The potential benefits of therapeutics based on
cloning technologies are considerable, and hasty legislation to ban all such
procedures could block progress in critical arenas of biomedical research
Subject
Developmental Biology,Endocrinology,Genetics,Molecular Biology,Animal Science and Zoology,Reproductive Medicine,Biotechnology
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献